Kev piav txog
Peb cov tshuaj Tofacitinib Qib tseem muaj lub npe hu ua CIS-1-Benzyl-4-Methyl-4-Methyl-3-Methylas-3-Methylraminopipipemeridididididididide thiab muaj tus lej lej 1062580-52-2. Lub Intermediate yog cov khoom siv tseem ceeb hauv kev tsim cov tofacitinib, tshuaj siv los kho mob caj dab, potoriatic caj dab thiab mob plab. Raws li qhov tseem ceeb intermediates nyob rau hauv synthesis ntawm Sofacitinib, peb cov khoom yog qhov tseem ceeb rau cov kws tshawb fawb thiab cov chaw tsim khoom.
Qhov kev sib txuas nruab nrab no yog ua kom zoo rau cov txiaj ntsig kom ntseeg tau tias qhov siab tshaj plaws ntawm kev coj dawb huv thiab xwm yeem. Nrog peb lub xeev-ntawm-cov txheej txheem tsim qauv thiab kev nruj kev tsim nyog tswj kev ntsuas, feem ntau yog cov qauv kev lag luam siab tshaj plaws rau kev coj dawb huv thiab ruaj khov.
Toffacitinib Intermediat (3R, 4R)-4-Benzyl-3- (mmethylide muaj ntau cov ntawv thov, ua rau nws muaj txiaj ntsig zoo nyob hauv cov cuab yeej thiab tshuaj tshawb xyuas. Txawm hais tias koj tau tshawb nrhiav kev kawm lossis tsim cov chaw muag tshuaj, peb cov kev daws teeb meem nruab nrab muab cov kev txhim khu kev qha thiab cov kev xav tau.
Xaiv Peb
JDK muaj cov chaw ua haujlwm thawj chav ua haujlwm thiab cov khoom tswj tau zoo, uas paub tias cov khoom siv tau ntawm API Intermediates. Cov kws tshaj lij kev paub tseeb R & D ntawm cov khoom. Tawm tsam ob, peb tab tom tshawb rau cmo & cdmo hauv kev ua lag luam hauv tsev thiab thoob ntiaj teb.
